Scopolamine for Memory Organization Syndrome

This trial tests scopolamine to assess its effects on memory and navigation skills in people with epilepsy undergoing brain monitoring. Researchers aim to understand how different brain regions manage event memory, such as taking medicine, compared to spatial navigation. This understanding could lead to new treatments for memory issues following a stroke or brain injury. People with epilepsy who have electrodes placed in their brain to monitor seizures might be suitable candidates for this trial. As an Early Phase 1 trial, this research focuses on understanding scopolamine's effects in people, offering participants a chance to contribute to groundbreaking insights into brain function and memory.

Yes, if you are currently using anticonvulsant, neuroleptic, sedatives, or other medications known to affect cognition, you will need to stop taking them to participate in the trial.

Research has shown that scopolamine has been used to study memory loss, particularly when administered by injection. Studies indicate it can impair memory and attention. Some research also suggests that scopolamine might help prevent certain brain changes related to epilepsy in animals.

Reports indicate that scopolamine can cause symptoms similar to delirium and increase anxiety in some cases. It may temporarily affect brain function but does not cause permanent damage.

Most treatments for Memory Organization Syndrome focus on managing symptoms through cognitive therapy and medications that enhance neurotransmitter activity. But scopolamine works differently, targeting the cholinergic system in the brain to affect memory processing directly. Researchers are excited about scopolamine because it has the potential to quickly modulate memory pathways, which might offer faster relief and new insights into memory disorders compared to traditional methods. This approach could open up new avenues for understanding and treating memory-related conditions beyond what's currently possible.

Research has shown that scopolamine is well-known for causing memory problems. Studies use it to understand memory loss because it blocks certain brain receptors, mimicking memory issues similar to those in Alzheimer's disease. Although primarily associated with memory difficulties, these effects help researchers explore memory mechanisms and could lead to new treatments. In this trial, participants will receive scopolamine on one day and a placebo on another to further investigate its effects on memory. However, current evidence mainly highlights its role in causing memory problems rather than improving memory.¹⁶⁷⁸⁹